Disclosures for "Application of NMOSD IPND-2015 Criteria in AQP4-IgG Positive, MOG-IgG Positive and Seronegative Inflammatory Demyelinating Diseases"
-
Samira Apostolos-Pereira has nothing to disclose.
-
Mr. Mahler Ferreira Oliveira has nothing to disclose.
-
Mr. Diogo Silva has nothing to disclose.
-
Dr. Schoeps has nothing to disclose.
-
Dr. Ayroza Galvao Ribeiro Gomes has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Guidepoint. The institution of Dr. Ayroza Galvao Ribeiro Gomes has received research support from Roche.
-
Dr. Mendes has nothing to disclose.
-
The institution of Dr. Matos has received research support from Hoffmann LaRoche.
-
Miss Solti has nothing to disclose.
-
Dr. Torretta has nothing to disclose.
-
Mrs. Pitombeira has nothing to disclose.
-
Dr. Boaventura de Olivei has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Dr. Boaventura de Olivei has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
-
Dr. Paolilo has nothing to disclose.
-
Dr. Rimkus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Rimkus has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Guerbet. Dr. Rimkus has received research support from Multiple Sclerosis International Federatio .
-
Dr. Adoni has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Adoni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis.
-
The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Proebstel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Proebstel has received research support from Biogen. Dr. Proebstel has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. Dr. Sato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Sato has received research support from Biogen. The institution of Dr. Sato has received research support from Merck.
-
Dr. Callegaro has nothing to disclose.